# Effect of Celecoxib on Postoperative Analgesia and Disease Severity in AERD Patients with CRS

> **NCT04147013** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's** · enrollment: 44 (estimated)

## Conditions studied

- Chronic Rhinosinusitis with Nasal Polyps
- Aspirin-exacerbated Respiratory Disease

## Interventions

- **DRUG:** Celecoxib
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04147013
- **Lead sponsor:** London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-02-18
- **Primary completion:** 2026-02
- **Final completion:** 2026-07
- **Target enrollment:** 44 (ESTIMATED)
- **Last updated:** 2024-10-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04147013

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04147013, "Effect of Celecoxib on Postoperative Analgesia and Disease Severity in AERD Patients with CRS". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04147013. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*